CAROL FRENTRESS: Open Payments
NPI 1982262028 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 10 payments from 8 companies in 2025. Trend: 2023 $176 · 2024 $317 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 1 | $39 |
| ABBVIE INC. | 2 | $36 |
| ARRAY BIOPHARMA INC | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Incyte Corporation | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: TECVAYLI, XALKORI, PLUVICTO, Vanflyta, Tecentriq, Polivy, JAKAFI, LYNPARZA.
Industry payments across TX — which companies pay providers there.
